Institute of Developmental and Regenerative Medicine (IDRM)

Director

Paul Riley

BHF Professor of Regenerative Medicine & Chair of Development and Cell Biology

What's new

Inaugural winners of the DPAG Prize for Public Engagement with Research announced

11 January 2023

Shaping Destiny team showcases virtual reality experience

16 December 2022

An image resembling tree roots branching out shows the development of the blood vessels on the outside surface of the heart called the epicardium.

Joaquim Vieira recognised in national image competition

9 November 2022

DPAG Myth Busters and Shaping Destiny teams engage the public at IF Oxford 2022

12 October 2022

BHF funded DPAG projects to receive share of £2 million raised by the London Marathon

5 October 2022

The Institute of Developmental and Regenerative Medicine (IDRM) is a unique flagship institution, at the University of Oxford, dedicated to meeting an ambitious challenge: two thirds of all deaths world-wide are due to non-communicable diseases, many of which are cardiovascular, neurological or immune system disorders that have a developmental origin, representing an urgent unmet clinical need. The mission of the IDRM is the development of new drugs and therapeutic strategies to tackle these chronic illnesses.

At its core is a formal merger of developmental biology and regenerative medicine in the form of 15-20 world leading research groups comprising 240 cardiovascular, neuroscience and immunology scientists integrating their expertise to foster multidisciplinary collaborations.

Learn more about the IDRM